Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

CURRICULUM VITAE

Julie-An M. Talano MD
Professor
Department of Pediatrics
Division of Hematology and Oncology - Pediatrics

OFFICE ADDRESS:
MACC Fund Research Center
8701 Watertown Plank Rd
Milwaukee, WI 53226

EDUCATION:
08/1987 - 05/1991 B.S. (Biology), Georgetown University, Washington
08/1991 - 06/1995 M.D., Northwestern University, Chicago, Illinois

POSTGRADUATE TRAINING AND FELLOWSHIP APPOINTMENTS:
06/1995 - 06/1998 Resident, Pediatrics, Northwestern University, Children's Memorial Hospital Chicago, IL
07/1999 - 10/2002 Fellowship, Pediatric Hematology, Oncology Medical College of Wisconsin, Milwaukee, WI
10/2002 - 03/2004 Fellowship, Pediatric Bone Marrow Transplant, Medical College of Wisconsin, Milwaukee, WI

FACULTY APPOINTMENTS:
07/1998 - 06/1999 Instructor of Pediatrics, Northwestern University, Children's Memorial Hospital, Highland Park Hospital, Highland Park, IL; Chicago, IL
07/1999 - 03/2004 Fellow, Instructor of Pediatrics, Oncology, BMT, Medical College of Wisconsin, Division of Hematology, Children's Hospital of Wisconsin, WI
04/2004 - 05/2011 Assistant Professor of Pediatrics, Oncology, BMT, Medical College of Wisconsin, Division of Hematology, Children's Hospital of Wisconsin, WI
06/2011 - 06/2018 Associate Professor of Pediatrics, Oncology, BMT, Medical College of Wisconsin, Division of Hematology, Children's Hospital of Wisconsin, WI
07/2018 - Present Professor of Pediatrics, Medical College of Wisconsin, Pediatrics, Hematology, Oncology and BMT, Children's Wisconsin, WI

HOSPITAL AND CLINICAL ADMINISTRATIVE APPOINTMENTS:
01/2005 - Present Member of Blood Usage Committee, Children's Hospital of Wisconsin, Milwaukee, WI
06/2013 - Present Member of the Pediatric Hematology Oncology Fellowship Committee, Medical College of Wisconsin
01/2020 - Present Medical Director of Bone Marrow Transplant and Cellular Therapy, Pediatrics, Hematology, Oncology and BMT, Medical College of Wisconsin, WI

RESEARCH ADMINISTRATIVE APPOINTMENTS:
07/2005 - 2014 Member, Institutional Review Board, BloodCenter, Milwaukee, WI
07/2009 - Present Director, Clinical Research in Pediatric Blood and Marrow Transplant, Medical College of Wisconsin/Children's Hospital of Wisconsin, Milwaukee, WI
01/2017 - Present Co-Director, Developmental Therapeutics in Pediatric Oncology and Blood and Marrow Transplant, Medical College of Wisconsin/Children's Hospital of Wisconsin, Milwaukee, WI
06/2017 - Present Member, Institutional Biosafety Committee, Medical College of Wisconsin, Milwaukee, WI
01/2018 - Present Director of Clinical Research in Cellular Therapy, Pediatrics, Hematology, Oncology and BMT, Medical College of Wisconsin, Milwaukee, WI
06/2018 - Present Member of Human Gene Transfer (non-cancer) Scientific Review Committee, Pediatrics, Hematology, Oncology and BMT, Medical College of Wisconsin, Milwaukee, WI

HOSPITAL STAFF PRIVILEGES:
07/1999 - Present Children's Hospital of Wisconsin, 9000 W. Wisconsin Ave., Wauwatosa, WI 53226

SPECIALTY BOARDS AND CERTIFICATION:
Board Certified
Issue DateExpiration
General Pediatrics
10/1998
12/2025
Pediatrics Hematology/ Oncology
11/2004
12/2024
 
Licensure
Number Issue DateExpiration
Illinois License (Expired)
1997
None
Wisconsin License
40981-020
1999
10/31/2021
 

AWARDS AND HONORS:
05/1991 George Chapman Meda, awarded for most outstanding senior thesis in the biological sciences, Georgetown University
06/1992 National Institutes of Health Fellowship, National Cancer Institute Student Research Program
12/1994 DuPage Medical Society Foundation Scholarship, awarded in recognition of demonstrated academic achievement and dedication to a career in medicine, DuPage Medical Society
04/2002 First Place Fellow clinical Research Award, Children's Hospital of Wisconsin Research Day
07/2002 Awarded a fellowship to attend the American Association of Cancer Research, American Society of clinical Oncology Workshop on Methods in Clinical Cancer Research
11/2006 Best Abstract, National Marrow Donor Program Council Meeting
2009 - 2020 Included in Best Doctors in America
06/2014 Best Abstract, MCW Cancer Center Scientific Retreat, $500 travel reward

MEMBERSHIPS IN HONORARY AND PROFESSIONAL SOCIETIES:
1991 - Present Sigma Xi Scientific Research Honor Society
1995 - 2005 American Academy of Pediatrics
1999 - Present American Society of Hematology
2000 - Present American Society of Pediatric Hematology/ Oncology
2006 - Present American Society for Blood and Marrow Transplantation
2010 - Present American Society of Cellular and Gene Therapy
2011 - Present Histiocyte Society

EDITORSHIPS/EDITORIAL BOARDS/JOURNAL REVIEWS:
Editorship
08/2012 - Present CTSI Grant Reviewer
2018 - Present Associate Editor Pediatric Blood and Cancer
Journal Review
2006 - Present Pediatric Hematology and Oncology
2008 - Present Pediatric Blood and Cancer
2014 - Present Pediatric Transplantation
2015 - Present Bone Marrow Transplantation
2016 - Present American Journal of Medical Genetics
2016 - Present PLOS Medicine
2017 - Present Blood Advances
2017 - Present Leukemia Lymphoma
2017 - Present Biology of Blood and Marrow Transplantation

LOCAL/REGIONAL APPOINTED LEADERSHIP AND COMMITTEE POSITIONS:
2006 - 2008 Member, Board of Directors, One Step at A Time Camp/ Children's Oncology Services
2008 - 2010 Captain, Annual Giving Drive, Lake Forest Country Day School
2009 - Present Member, President's Circle, Chicago Botanic Gardens
2011 - 2013 Sub-committee Chair, School Fund-raising Auction, Lake Forest Country Day School
2011 - 2013 Member, Head of School Search Committee, Lake Forest Country Day School
2012 - 2015 Member, Patron Society, Music Institute of Chicago
2013 - 2015 Executive Board Member, Parent Association, Lake Forest Country Day School
2015 - 2019 Member, Annual Auction Committee for Scholarships, Loyola Academy
2016 - Present Member, Committee for Fundraising, Cove School for Children with Learning Disabilities
2019 - Present Member, Alumni Interviewer for Undergraduate Students, Northwestern University
2020 - Present Member, Parent Leadership Council, Georgetown University

NATIONAL ELECTED/APPOINTED LEADERSHIP AND COMMITTEE POSITIONS:
02/2009 - Present Member, Pediatric Cancer Working Committee, Center for International Blood and Marrow Transplant Research
10/2009 - 12/2011 Member, Supportive Care Working Committee, Pediatric Blood and Marrow Transplant Consortium
2009 - 2015 Associate Faculty Member, Faculty of 1000 Medicine
01/2011 - Present Steering Committee Member, Multi-institutional Consortium for Haploidentical Transplantation for Patients with Sickle Cell Disease
10/2011 - 2013 Organizing Committee, ASPHO Bone Marrow Transplant Workshop, ASPHO/PBMTC
01/01/2012 - 2016 Member, Treosulfan BMT Protocol Team, Pediatric Blood and Marrow Transplant Consortium (PBMTC)
07/01/2012 - Present Member, Steering Committee, Pediatric Blood and Marrow Transplant Consortium (PBMTC)
08/2012 - 07/2017 Member, Hemophagocytic Histiocytosis BMT Protocol Team, Pediatric Blood and Marrow Transplant Consortium (PBMTC)
06/2013 - 2018 DSMB, HPDSC Trial
06/2013 - 07/2017 Vice Chair, Non Malignant Study, Pediatric Blood and Marrow Transplant Consortium
02/2015 - 2017 Pediatric Special Interst Group (PSIG) Steering Committe, ASBMT
05/2015 - 05/2016 Vice Chair, Pediatric Blood and Marrow Transplant Annual Education Meeting, PBMTC
05/2015 - 05/2017 Program Committee, American Society of Pediatric Hematology Oncology Annual Meeting
05/2016 - 05/2017 Chair, Pediatric Blood and Marrow Transplant Annual Education Meeting, PBMTC
11/2017 - Present Member at Large, Executive Committee, Peds Blood & Marrow Transplant Consortium
10/2018 - 12/2019 Member, Non-Malignant Disease Task Force, Blood and Marrow Clinical Trial Network
10/2018 - Present Member, Cancer Symposium Organizing Committee, Northwester Mutual
10/2018 - Present Member, Education Committee, International Histiocyte Society
10/2019 - Present Member, Protocol Team Member, CTN Trial 1904 Treosulfan for Bone Marrow Failure

RESEARCH GRANTS/AWARDS/CONTRACTS/PROJECTS:
Active
Peer Review
Title:
Allogeneic hematopoietic cell transplantation for patients with nonmalignant inherited disorders using a Treosulfan based preparative regimen
Source:
Fred Hutchinson Cancer Research Center
Role:
Site Principal Investigator
Dates:
01/18/2010 - 02/19/2021
 
Title:
Unrelated and Partially Matched Related Donor Peripheral Stem Cell Transplantation with  T Cell and B Cell Depletion For Patients with Hematologic Malignancies
Source:
Miltenyi
Role:
Institutional PI, IDE holder
Dates:
06/01/2016 - 06/30/2021
Direct Funds:
$100,000
 
Title:
The PBMTC Study No. 1401 entitled, “The Role of KIR-favorably Mismatched Haploidentical Transplantation and KIR-polymorphisms in Determining Outcomes of Children with ALL/AML/MDS Undergoing Allogeneic Hematopoietic Cell Transplantation”
Source:
Children’s Hospital Los Angeles
Role:
Site Principal Investigator, Protocol Study Committee Team
Dates:
12/15/2016 - 08/31/2021
 
Title:
Optimizing Cord Blood and Haploidentical Aplastic Anemia Transplantation (CHAMP), BMT CTN Protocol #1502
Source:
Children’s Hospital Los Angeles
Role:
Site Principal Investigator, Protocol Study Committee Team
Dates:
03/30/2017 - 08/31/2020
 
Title:
A Multi-Institutional Pilot Study in the Treatment of Refractory Cytomegalovirus (CMV), Adenovirus (ADV), EBV Infections with Related Donor CMV Specific Cytotoxic T-cells (CTLs) in Children, Adolescents and Young Adult Recipients
Source:
New York Medical College/Miltenyi and Snowdrop Foundation – Children’s Hospital of Wisconsin/Children’s Research Institute
Role:
Co-Study Chair
Dates:
06/01/2017 - 05/31/2022
 
Title:
FY20 C-MACC (Midwest Athletes Against Childhood Cancer) Funding
Source:
Children’s Hospital of Wisconsin/Children’s Research Institute
Role:
Co-Principal Investigator (PI: Dr. Michael Burke)
Dates:
07/01/2017 - 06/30/2021
Direct Funds:
$92,031
 
Title:
Core Clinical Centers for the Blood and Marrow Transplant Clinical Trials Network
Source:
NIH Heart Lung and Blood Institute (PI: Hari)
Role:
Co-Investigator
Dates:
07/01/2017 - 06/30/2024
Direct Funds:
$120,000
 
Title:
Defibrotide Prophylaxis in High Risk SCD Patients Receiving Myeloablative Conditioning and Haploidentical Allogeneic Stem Cell Transplant IND127812 9-3-15
Source:
New York Medical College FDA R01 Renewal (PI: Cairo)
Role:
Consortium Lead Clinical Investigator, Steering Committee Member, Executive Committee Member
Dates:
01/01/2018 - 08/31/2021
Direct Funds:
$23,630
 
Title:
Phase 1 Study of Autologous T Cells Engineered to Contain an Anti CD19 and anti CD20 in Pediatric Patients with Relapsed/Refractory ALL
Source:
Children’s Hospital of Wisconsin/Children’s Research Institute
Role:
Principal Investigator
Dates:
03/01/2019 - 02/29/2022
Direct Funds:
$10,000
 
Title:
FY20 M-MACC (Midwest Athletes Against Childhood Cancer) Funding
Source:
Children’s Hospital of Wisconsin/Children’s Research Institute
Role:
Co-Principal Investigator
Dates:
07/01/2019 - 06/30/2020
Direct Funds:
$198,923
 
Title:
Dissecting the Cellular Mechanisms of Differential Outcomes of CD20-19 CAR-T Therapy in Acute Lymphoblastic Leukemia (ALL)
Source:
Children’s Hospital of Wisconsin/Children’s Research Institute
Role:
Principal Investigator
Dates:
01/01/2020 - 12/31/2020
Direct Funds:
$250,000
 
Title:
CART 1920 for Relapsed Refractory ALL
Source:
Vince Lombardi Cancer Foundation
Role:
Principal Investigator
Dates:
07/01/2020 - 06/30/2021
Direct Funds:
$62,500
 
Prior
Peer Review
Title:
Kidney Response to Response to Radiation and Chemotherapy
Source:
5RO1 CAO 24652 PI Moulder
Role:
Co-Investigator
Dates:
12/01/2002 - 11/30/2007
 
Title:
Partially CD3-Depleted Alternative Donor PSCT for Pediatric Hematologic Malignancies
Source:
Miltenyi Biotec
Role:
Principal Investigator, IDE holder
Dates:
01/01/2005 - 06/20/2015
 
Title:
Phase 1 Multi-viral CTLs for Recipients of Grafts Rigorously Depleted of T Cells
Source:
Clinical & Translational Science Institute
Role:
Co-Principal Investigator
PI:
Taylor, Carolyn PhD & Talano, Julie MD
Dates:
06/01/2011 - 05/31/2015
Direct Funds:
$50,000
 
Title:
Phase 1 Multi-viral CTLs for Recipients of Grafts Rigorously Depleted of T Cells
Source:
Clinical & Translational science Institute, Hyundai Hope on Wheels, Miltenyi, HOOT Fund, MACC FUND
Role:
Principal Investigator, IND holder
Dates:
06/01/2011 - 05/31/2019
Direct Funds:
$50,000
 
Title:
Clofarabine in Combination with Cytarabine & Total Body Irradiation Followed by Allogeneic Stem Cell Transplantation in Children w? Acute Lymphoblastic Leukemia
Source:
New York Medical College
Role:
Principal Investigator
Dates:
09/20/2011 - 09/19/2014
 
Title:
NYMC-526: Familial Haploidentical T-Cell Depleted Transplantation in High-Risk Sickle Cell Disease (IND 14359)
Source:
New York Medical College
Role:
Principal Investigator
Dates:
03/31/2012 - 03/31/2017
 
Title:
Hyundai Hope on Wheels for Pediatric Cancer Award
Source:
Hyundai/children's Hospital of Wisconsin
Role:
Principal Investigator
Dates:
09/01/2012 - 08/31/2015
Direct Funds:
$250,000
 
Title:
A Phase 1 Trial to Determine Safety and Tolerability of Ex Vivo Expanded Human Myeloid Progenitor Cells (CLT-008) Infused 24 Hours Post-Transplant to Support Allogeneic Umbilical Cord Transplantation for Hematologic Malignancies
Source:
Cellerant Therapeutics
Role:
Principal Investigators
Dates:
04/04/2013 - 04/03/2014
 
Title:
A Phase II Study of Treosulfan/Fludarabine/Low Dose Total Body Irradiation as a Preparative Regiment for Children with AML/MDS Undergoing Allogeneic Cell Transplantation
Source:
National Marrow Donor Program
Role:
Principal Investigator
Dates:
05/15/2013 - 01/15/2018
 
Title:
Project 3 - Clinical and Outcomes Research
Source:
Children's Hospital of Wisconsin
Role:
Co-Principal Investigators
Dates:
01/01/2014 - 06/30/2015
Direct Funds:
$4,000
 
Title:
A Phase 3, Open-Label, Multicenter Study of the Safety and Efficacy of Brincidofovir (CMX001) in the Treatment of Early versus Late Adenovirus Infection
Source:
Chimerix, Inc.
Role:
Principal Investigator
Dates:
03/12/2014 - 06/02/2017
 
Title:
Minimal Residual Disease Testing in HSCT for Pediatric AML, CIBMTR Protocol #09-MRD
Source:
National Marrow Donor Program
Role:
Principal Investigator
Dates:
03/17/2014 - 12/02/2015
 
Title:
Natural History and Biology of Long-Term Late Effects Following Hematopoietic Cell Transplant for Childhood Hematologic Malignancies
Source:
National Marrow Donor Program
Role:
Principal Investigator
Dates:
02/19/2015 - 01/24/2020
 
Title:
A multicenter study to obtain retrospective data for subjects previously diagnosed with Adenovirus Infection to serve as matched historical controls for Study CMX001-304
Source:
Chimerix, Inc.
Role:
Principal Investigator
Dates:
06/17/2015 - 06/16/2017
 
Title:
A Single-arm, Prospective Study of Remestemcel-L, Ex-vivo Cultured Adult Human Mesenchymal Stromal Cells, for the Treatment of Pediatric Patients who Have Failed to Respond to Steroid Treatment for Acute GVHD. (MSB_GVHD001)
Source:
Mesoblast, Inc.
Role:
Principal Investigator
Dates:
07/01/2015 - 12/03/2018
 
Title:
An Intermediate-size, Expanded Access Protocol to Provide Brincidofovir for the Treatment of Serious Adenovirus Infection or Disease
Source:
Chimerix, Inc.
Role:
Site Principal Investigator
Dates:
12/08/2015 - 12/04/2019
 
Title:
Safety Follow-Up through 180 Days of Treatment with Remestemcel-L In Study MSB-GVHD001 in Pediatric Patients Who Have Failed To Respond to Steroid Treatment for Acute GVHD. (MSB-GVHD002)
Source:
Mesoblast, Inc.
Role:
Principal Investigator
Dates:
01/19/2016 - 11/30/2018
 
Title:
A Phase 1/2 Multi-Center Study Evaluating the Safety and Efficacy of KTE-C19 in Pediatric and Adolescent Subjects with Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (r/r ALL)
Source:
Kite Pharma, Inc.
Role:
Co-Principal Investigator (Site Co-PI: Dr. Michael Burke)
Dates:
09/29/2016 - 05/13/2020
 
Title:
Practice patterns and incidence of adenovirus infections in hematopoietic cell transplant in the United States Advance US (Survey)
Source:
Analytica La-Ser International, Inc.
Role:
Site Principal Investigator
Dates:
07/30/2018 - 07/29/2019
 
Title:
An Open-label, Randomized, Multi-Center, Parallel Group, Two-arm Study to Assess the Safety, Overall Tolerability, and Antiviral Activity of Brincidofovir versus Standard of Care for Treatment of Adenovirus Infections in High-risk Pediatric Allogeneic Hematopoietic Cell Transplant Recipients.
Source:
Chimerix, Inc.
Role:
Site Principal Investigator
Dates:
11/15/2018 - 11/14/2019
 
Non-Peer Review
Title:
Recombinant Growth Hormone in Haploidentical Hematopoietic Stem Cell Transplantation to Promote Immue Reconstitution
Source:
Genentech Center for Clinical Research in Endocrinology
Role:
Principal Investigator
Dates:
09/2003 - 09/2004
Direct Funds:
$150,000
 
Title:
A Phase III, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Prochymal™ (Ex-vivo Cultured Adult Human Mesenchymal Stem Cells) Infusion for the Treatment of Patients Who Have Failed to Respond to Steroid Treatment for Acute GVHD
Source:
Osiris Therapeutics
Role:
Principal Investigator
Dates:
01/01/2007 - 2009
 
Title:
A Dose Escalation Study of Clofarabine in Combination with Cytarabine and Total Body Irradiation Followed by Allogeneic Hematopoietic Progenitor Cell Transplantation in Children with Acute Lymphoblastic Leukemia in Third Complete Remission
Source:
Columbia University
Role:
Principal Investigato
Dates:
03/31/2009 - 03/31/2012
 
Title:
Expanded Access of Prochymal Infusion for the Treatment of patients Who have Failed to Respond to Steroid Treatement for Acute GVHD
Source:
Osiris Therapeutics, Inc.
Role:
Princiapl Investigator
Dates:
05/06/2009 - 12/31/2015
 
Title:
Multi-National Historical Cohort Controlled Study to Evaluate Efficacy and Safety of Tranplantation of temEx, Umbilical Cord Blood Stem and progenitor Cells Expanded Ex vivo, in Subjects with Hematologic Malignancies Following Myeloablative Conditioning
Source:
Gamida Cell - Teva Joint Venture Ltd.
Role:
Principal Investigator
Dates:
11/15/2010 - 11/14/2012
 
Title:
Haploidentical Tranplantation for patients with sever Sickle Cell Disease
Source:
Busulfex
Role:
Co-Principal Investigator
Dates:
01/01/2012 - 12/31/2013
Direct Funds:
$25,000
 

INVITED LECTURES/WORKSHOPS/PRESENTATIONS:
Local
Low Day 100 Transplant-Related Mortality and Relapse Rate Following Clofarabine in Combination with Cytarabine, Total Body Irradiation and Allogenic Stem Cell Transplantaiton in Children, Adolescents and Young Adults with Poor-Risk Acute Leukemia, ASBMT 2014/ Cancer center retreat - Oral Presentation, Medical College of Wisconsin, Milwaukee, WI, 02/2014
 
Regional
Immune Reconstitution post Bone Marrow Transplant, Children’s Memorial Hospital, Chicago, IL, 2005
Participation as an expert in Pediatric CGVHD, NIH sponsored Chronic Graft versus Host Disease Symposium, Chicago, IL, 07/2006
 
National
Prevention of Veno Occlusive Disease Post Bone Marrow Transplantation, Pediatric Blood and Marrow Transplant Consortium, Dallas, TX, 10/2009
Ongoing Presentation as Board Member for Non Malignant Board Meeting Bimonthly, Seattle Fred Hutchinson Research Institute, WA, 01/2010
Pediatric Acute Leukemia, Advisory Board Meeting Presentation, Dallas, TX, 07/2010
Use of Clofarabine for Allogeneic BMT, Pediatric Blood and Marrow Transplant Consortium, Dallas, TX, 09/2010
Calfactant for Respiratory Failure in Bone Marrow Transplant Patients, Pediatric Blood and Marrow Transplant Consortium, Dallas, TX, 09/2010
Pediatric Acute Graft versus Host Disease, Advisory Board Meeting, Chicago, IL, 04/2011
Pediatric Non Malignant Bone Marrow Transplant Meeting, PBMTC, Dallas, TX, 09/2013 - 2015
Familial Haploidentical (FHI) T-Cell Depleted (TCD) with T-Cell Addback Stem Cell Transplantation for Patients with High-Risk Sickle Cell Disease (SCD) (IND 14359), ASBMT 2014 - Poster Presentation, Dallas, TX, 02/2014
Critical Care of the Immunocompromised Pediatric Hematology/Oncology Patient, American Society of Pediatric Hematology Oncology, Educational Session Moderator, Montreal Canada, 04/2017
T cell Adoptive Therapy for Cancer. Harnessing T cells for Allogeneic Transplantation in Pediatric Hematologic Malignancies, Fourth Annual Northwestern Mutual Northwestern Mutual Pediatric Cancer Symposium, Milwaukee, WI, 05/2017
Allogeneic Hematopoietic Stem cell Transplantation for Pediatric Patients with ALL in the Era of Tyrosine Kinase Inhibitors, Novel Immunotherapies and MRD Statu, American Society of Pediatric Hematology Oncology, Educational Session Moderator, Montreal Canada, 05/2017
Alpha Beta T cell Depletion in Bone Marrow Transplant for Children with Pediatric Hematologic Malignancies, Milteyi Biotec Lecture, Chicago, IL, 10/2019
Bone Marrow Transplant Session with Luminary Speaker, American Society of Pediatric Hematology, Oncology,, Minneapolis, MN, - 05/2016
Intensive Care outside the Bone Marrow Transplant Ward, Annual meeting of the American Society o fbone Marrow Transplant, Hawaii, - 02/2016
Pediatric Blood and marrow Transplant Consortium Steering Committee, Pediatric Blood and marrow transplant Consortium, Chicago, IL, - 05/2014
Extracorpeal Photopheresis for Pediatric Acute Graft versus Host Disease, Pediatric Grand Rounds, New York Medical Center, Westchester, NY, - 04/2016
Immune Reconstitution post Bone Marrow Transplant, PBMTC/ASPHO, Miami, FL, - 04/2013
Prevention of Relapse post Bone Marrow Transplant, ASBMT, San Diego, CA, - 02/2012
 
International
Hemophagocytic Lymphoproliferative Histiocytosis (HLH) Mimicking Neonatal Hemochromatosis, Histiocyte Meeting - Poster Presentation, Toronto, Canada, 10/2014
 

COMMITTEE SERVICE:
Medical College of Wisconsin
07/01/2012 - 06/2017 Committee Member, Fellowship Committee, Pediatric, Hematology Oncology, Medical College of Wisconsin
06/2016 - Present Fellowship Director, Pediatric Blood and Marrow Transplant Fellowship, Hematology, Oncology and BMT, Pediatrics, Medical College of Wisconsin
05/01/2017 - Present Committee Member, Institutional Biosafety Committee, Medical College of Wisconsin
10/2018 - Present Committee Member, Human Gene Transfer (non-Cancer) Scientific Review, Hematology, Oncology and BMT, Pediatrics, Medical College of Wisconsin
 
Hospital
QI Committee, BMT, Children's Hospital of Wisconsin
Member, Blood Usage Committee, Children's Hospital of Wisconsin
 

MEDICAL COLLEGE TEACHING ACTIVITIES:
Medical Student Education
Cased Based Discussions, Preceptor Department of Biochemistry
Lecture, Viral Infections in Bone Marrow Transplant Patients
 
Resident and Fellow Education
Teaching attending, General Pediatrics, Attending Physician
Hematology/Oncology/Transplant Unit, Round with residents (and students) 10 weeks/year, Formal lectures on BMT
 
Continuing Medical Education
Hematology/Oncology/Transplant Unit Nursing Orientation, Fever, Neutropenia, Sepsis, Extracorporeal Photophoresis for Chronic Graft versus Host Disease
Hemophagocytic Lymphohistiocytosis, Bone Marrow Transplant, Research in Bone Marrow Transplant
How I treat Graft vs. Host disease
 
Postdoctoral Fellow Education
Hematology/Oncology/Bone Marrow Transplant Fellow Seminars, Topics presented include Indications for Bone Marrow Transplant, Donor Selection, Selection of Stem Cell Source, Histiocytosis, Transfusion
 

EXTRAMURAL TEACHING:
Community/Lay Public
Sheridan Elementary School, Student Education, Medical Education to Elementary School Students
Children's Hospital of Wisconsin, Nursing Education Series Presentation - Hemophagocytic Lymphohistiocytosis, Bone Marrow Transplant, Research in Bone Marrow Transplant
Lake Forest Country Day School, Student Education, Lecture to Kindergarten Students on Human Anatomy
 

MCW STUDENTS, FACULTY, RESIDENTS AND CLINICAL/RESEARCH FELLOWS MENTORED:
Medical Students
Jessica Brown, MCW, 06/01/2009 - 05/31/2010 Assist in development, execution, meeting presentation and manuscript preparation of research ideas
Allison Bock, MCW, 12/2013 - Present Pathways Mentor
Simon Newsom, MCW, 06/2015 - Present Pathways Mentor
 
Clinical/Research Fellows
Cheryl Cameron, MCW, 2009 - 2010 Assist in development, career guidance and support for fellows in pediatric hematology/oncology, Member of SOC Committee
Hemalatha Rangarajan, MCW, 2010 - 2012 Assist in development, career guidance and support for fellows in pediatric hematology/oncology, Member of SOC Committee
Chelsea Collins, MCW, 2010 - 2013 Assist in development, career guidance and support for fellows in pediatric hematology/oncology, Member of SOC Committee
Anna Vinitsky, MCW, 2012 - 2015 Clinical Research Mentor, Assist in development, career guidance and support for fellows in pediatric hematology/oncology
Neel Bhatt, MCW, 2016 - 2018 Clinical Research Mentor, Assist in development, career guidance and support for fellows in pediatric hematology/oncology, Member of SOC Committee
Larissa Broglie, MCW, 2016 - 2018 Bone Marrow Transplant Fellow Mentor, Assist in development, career guidance support
Kerri Becktell, Medical College of Wisconsin, 2017 - 2019, Assist in development, career guidance and support for fellows in pediatric hematology/oncology, Member of SOC committee
Amy Moskop, Medical College of Wisconsin, 2018 - Present, Assist in development, career guidance and support for fellows in pediatric hematology/oncology/BMT/cellular therapy
Loyna Melinkov, Medical College of Wisconsin, 2020 - Present, Asist in the developmet, career guidance and support for fellows in pediatric hematology/oncology, Member of SOC Committee
 


BIBLIOGRAPHY
Refereed Journal Publications/Original Papers
1. Stetler-Stevenson WG, Kreck ML, Talano JA. Assaying Type IV Collagenase Activity Using [3H] Pepsinized Human Placental Type IV Collagen. DuPont Biotech Update. 1990 Jun;15(3)54-55
2. Stetler-Stevenson WG, Talano JA, Gallagher ME, Krutzsch HC, Liotta LA. Inhibition of human type IV collagenase by a highly conserved peptide sequence derived from its prosegment. Am J Med Sci. 1991 Sep;302(3):163-70.
3. Talano JA. Development of a Fluorogenic Assay for Type IV Collagenase and the Characterization of Inhibition by Tissue Inhibitor Metalloproteinase-2 (Timp-2). Senior Thesis, Department of Biology, Georgetown University, 1991. Presented, National Cancer Institute, Section of Tumor Invasion and Metastases, May, 1991. Presented, Georgetown University, Department of Biology, May, 1991.
4. Talano JA, Katz BZ. Long-term follow-up of children with fever of unknown origin. Clin Pediatr (Phila). 2000 Dec;39(12):715-7.
5. Talano JA, Hillery CA, Gottschall JL, Baylerian DM, Scott JP. Delayed hemolytic transfusion reaction/hyperhemolysis syndrome in children with sickle cell disease. Pediatrics. 2003 Jun;111(6 Pt 1):e661-5.
6. Talano JM, Casper JT, Camitta BM, Keever-Taylor CA, Murray KJ, Eapen M, Pierce KL, Margolis DA. Alternative donor bone marrow transplant for children with Philadelphia chromosome ALL. Bone Marrow Transplant. 2006 Jan;37(2):135-41.
7. Talano JA, Margolis DA. Recent molecular and cellular advances in pediatric bone marrow transplantation. Pediatr Clin North Am. 2006 Aug;53(4):685-98.
8. Conlon JD, Dauenhauer M, Tonkovic-Capin V, Talano J, Margolis D, Drolet BA, Fairley JA. Voriconazole-induced blistering in the setting of graft versus host disease: A report of 2 patients. J Am Acad Dermatol. 2008 Mar;58(3):484-7.
9. Cohen EP, Irving AA, Drobyski WR, Klein JP, Passweg J, Talano JA, Juckett MB, Moulder JE. Captopril to mitigate chronic renal failure after hematopoietic stem cell transplantation: a randomized controlled trial. Int J Radiat Oncol Biol Phys. 2008 Apr 01;70(5):1546-51. PMCID: PMC2386758
10. Zidan H, Lo S, Wiebe D, Talano J, Alemzadeh R. Severe hypercholesterolemia mediated by lipoprotein X in a pediatric patient with chronic graft-versus-host disease of the liver. Pediatr Blood Cancer. 2008 Jun;50(6):1280-1.
11. Filicko-O'Hara J, Grosso D, Flomenberg PR, Friedman TM, Brunner J, Drobyski W, Ferber A, Kakhniashvili I, Keever-Taylor C, Mookerjee B, Talano JA, Wagner JI, Korngold R, Flomenberg N. Antiviral responses following L-leucyl-L-leucine methyl esther (LLME)-treated lymphocyte infusions: graft-versus-infection without graft-versus-host disease. Biol Blood Marrow Transplant. 2009 Dec;15(12):1609-19. PMCID: PMC2783272
12. Anderson L, Gregg D, Margolis D, Casper J, Talano J. Focal nodular hyperplasia in pediatric allogeneic hematopoietic cell transplant: case series. Bone Marrow Transplant. 2010 Aug;45(8):1357-9.
13. de Montalembert M, Dumont MD, Heilbronner C, Brousse V, Charrara O, Pellegrino B, Piguet C, Soussan V, Noizat-Pirenne F. Delayed hemolytic transfusion reaction in children with sickle cell disease. Haematologica. 2011 Jun;96(6):801-7. PMCID: PMC3105640
14. Prasad VK, Lucas KG, Kleiner GI, Talano JA, Jacobsohn D, Broadwater G, Monroy R, Kurtzberg J. Efficacy and safety of ex vivo cultured adult human mesenchymal stem cells (Prochymal™) in pediatric patients with severe refractory acute graft-versus-host disease in a compassionate use study. Biol Blood Marrow Transplant. 2011 Apr;17(4):534-41.
15. Biank VF, Sheth MK, Talano J, Margolis D, Simpson P, Kugathasan S, Stephens M. Association of Crohn's disease, thiopurines, and primary epstein-barr virus infection with hemophagocytic lymphohistiocytosis. J Pediatr. 2011 Nov;159(5):808-12. PMCID: PMC3191286
16. Rangarajan HG, Grochowski D, Mulberry MF, Gheorghe G, Camitta BM, Talano JA. Treatment of recurrent CNS disease post-bone marrow transplant in familial HLH. Pediatr Blood Cancer. 2012 Jul 15;59(1):189-90.
17. Freed J, Talano J, Small T, Ricci A, Cairo MS. Allogeneic cellular and autologous stem cell therapy for sickle cell disease: 'whom, when and how'. Bone Marrow Transplant. 2012 Dec;47(12):1489-98.
18. Bacher U, Talano JA, Bishop MR. Monitoring and prevention of relapse after allogeneic hematopoietic cell transplantation for myeloid malignancies. Biol Blood Marrow Transplant. 2012 Jan;18(1 Suppl):S62-73.
19. Duncan CN, Lehmann LE, Cheifetz IM, Greathouse K, Haight AE, Hall MW, Herschberger A, Hill KS, Moffet JR, Morrison RR, Norris AL, Petrovic A, Spear DA, Steiner ME, Talano JA, Tamburro RF, Wagner J, McArthur J, Pediatric Acute Lung Injury and Sepsis (PALISI) Network. Clinical outcomes of children receiving intensive cardiopulmonary support during hematopoietic stem cell transplant. Pediatr Crit Care Med. 2013 Mar;14(3):261-7.
20. Chellapandian D, Das R, Zelley K, Wiener SJ, Zhao H, Teachey DT, Nichols KE, EBV-HLH Rituximab Study Group. Treatment of Epstein Barr virus-induced haemophagocytic lymphohistiocytosis with rituximab-containing chemo-immunotherapeutic regimens. Br J Haematol. 2013 Aug;162(3):376-82. PMCID: PMC3776423
21. Rangarajan HG, Punzalan RC, Camitta BM, Talano JA. The use of novel Therakos™ Cellex® for extracorporeal photopheresis in treatment of graft-versus-host disease in paediatric patients. Br J Haematol. 2013 Nov;163(3):357-64.
22. Kurtzberg J, Prockop S, Teira P, Bittencourt H, Lewis V, Chan KW, Horn B, Yu L, Talano JA, Nemecek E, Mills CR, Chaudhury S. Allogeneic human mesenchymal stem cell therapy (remestemcel-L, Prochymal) as a rescue agent for severe refractory acute graft-versus-host disease in pediatric patients.Biol Blood Marrow Transplant. 2014 Feb;20(2):229-35. doi: 10.1016/j.bbmt.2013.11.001. Epub 2013 Nov 8.
23. Talano JM, Pulsipher MA, Symons HJ, Militano O, Shereck EB, Giller RH, Hancock L, Morris E, Cairo MS. New frontiers in pediatric Allo-SCT. Bone Marrow Transplant. 2014 Sep;49(9):1139-45. PMCID: PMC4439009
24. Burroughs LM, Nemecek ER, Torgerson TR, Storer BE, Talano JA, Domm J, Giller RH, Shimamura A, Delaney C, Skoda-Smith S, Thakar MS, Baker KS, Rawlings DJ, Englund JA, Flowers ME, Deeg HJ, Storb R, Woolfrey AE. Treosulfan-based conditioning and hematopoietic cell transplantation for nonmalignant diseases: a prospective multicenter trial. Biol Blood Marrow Transplant. 2014 Dec;20(12):1996-2003. PMCID: PMC4324724
25. Talano JA, Cairo MS. Smoothing the crescent curve: sickle cell disease. Hematology Am Soc Hematol Educ Program. 2014 Dec 05;2014(1):468-74.
26. Satwani P, Jin Z, Martin PL, Bhatia M, Garvin JH, George D, Chaudhury S, Talano J, Morris E, Harrison L, Sosna J, Peterson M, Militano O, Foley S, Kurtzberg J, Cairo MS. Sequential myeloablative autologous stem cell transplantation and reduced intensity allogeneic hematopoietic cell transplantation is safe and feasible in children, adolescents and young adults with poor-risk refractory or recurrent Hodgkin and non-Hodgkin lymphoma. Leukemia. 2015 Feb;29(2):448-55.
27. Talano JA, Cairo MS. Hematopoietic stem cell transplantation for sickle cell disease: state of the science. Eur J Haematol. 2015 May;94(5):391-9.
28. Oshrine B, Talano JA. Curative treatment for severe sickle cell disease: allogeneic transplantation. Clin Adv Hematol Oncol. 2015 Apr;13(4):249-56.
29. Burke MJ, Verneris MR, Le Rademacher J, He W, Abdel-Azim H, Abraham AA, Auletta JJ, Ayas M, Brown VI, Cairo MS, Chan KW, Diaz Perez MA, Dvorak CC, Egeler RM, Eldjerou L, Frangoul H, Guilcher GMT, Hayashi RJ, Ibrahim A, Kasow KA, Leung WH, Olsson RF, Pulsipher MA, Shah N, Shah NN, Thiel E, Talano JA, Kitko CL. Transplant Outcomes for Children with T Cell Acute Lymphoblastic Leukemia in Second Remission: A Report from the Center for International Blood and Marrow Transplant Research. Biol Blood Marrow Transplant. 2015 Dec;21(12):2154-2159. PMCID: PMC4654112
30. Morillo-Gutierrez B, Beier R, Rao K, Burroughs L, Schulz A, Ewins AM, Gibson B, Sedlacek P, Krol L, Strahm B, Zaidman I, Kalwak K, Talano JA, Woolfrey A, Fraser C, Meyts I, Müller I, Wachowiak J, Bernardo ME, Veys P, Sykora KW, Gennery AR, Slatter M. Treosulfan-based conditioning for allogeneic HSCT in children with chronic granulomatous disease: a multicenter experience. Blood. 2016 07 21;128(3):440-8. PMCID: PMC4957165
31. Bock AM, LeVeque M, Camitta B, Talano JA. Successful treatment of recurrent CNS disease post-bone marrow transplant in children with familial hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2016 12;63(12):2154-2158.
32. Marsh RA, Jordan MB, Talano JA, Nichols KE, Kumar A, Naqvi A, Vaiselbuh SR, Histiocyte Society Salvage Therapy Working Group. Salvage therapy for refractory hemophagocytic lymphohistiocytosis: A review of the published experience. Pediatr Blood Cancer. 2017 04;64(4).
33. Erker C, Harker-Murray P, Talano JA. Usual and Unusual Manifestations of Familial Hemophagocytic Lymphohistiocytosis and Langerhans Cell Histiocytosis. Pediatr Clin North Am. 2017 Feb;64(1):91-109.
34. Burroughs LM, Shimamura A, Talano JA, Domm JA, Baker KK, Delaney C, Frangoul H, Margolis DA, Baker KS, Nemecek ER, Geddis AE, Sandmaier BM, Deeg HJ, Storb R, Woolfrey AE. Allogeneic Hematopoietic Cell Transplantation Using Treosulfan-Based Conditioning for Treatment of Marrow Failure Disorders. Biol Blood Marrow Transplant. 2017 Oct;23(10):1669-1677. PMCID: PMC5605451
35. Broglie L, Pommert L, Rao S, Thakar M, Phelan R, Margolis D, Talano J. Ruxolitinib for treatment of refractory hemophagocytic lymphohistiocytosis. Blood Adv. 2017 Aug 22;1(19):1533-1536. PMCID: PMC5728466
36. Duncan CN, Brazauskas R, Huang J, Shaw BE, Majhail NS, Savani BN, Flowers MED, Battiwalla M, Beebe K, Dietz AC, Dvorak CC, Giller R, Jacobsohn DA, Kletzel M, Martin PL, Nemecek ER, Nuechterlein B, Talano JA, Pulsipher MA, Baker KS. Late cardiovascular morbidity and mortality following pediatric allogeneic hematopoietic cell transplantation. Bone Marrow Transplant. 2018 10;53(10):1278-1287. PMCID: PMC6158112
37. Connelly JA, Marsh R, Parikh S, Talano JA. Allogeneic Hematopoietic Cell Transplantation for Chronic Granulomatous Disease: Controversies and State of the Art. J Pediatric Infect Dis Soc. 2018 May 09;7(suppl_1):S31-S39. PMCID: PMC5946867
38. Nemecek ER, Hilger RA, Adams A, Shaw BE, Kiefer D, Le-Rademacher J, Levine JE, Yanik G, Leung W, Talano JA, Haut P, Delgado D, Kapoor N, Petrovic A, Adams R, Hanna R, Rangarajan H, Dalal J, Chewning J, Verneris MR, Epstein S, Burroughs L, Perez-Albuerne ED, Pulsipher MA, Delaney C. Treosulfan, Fludarabine, and Low-Dose Total Body Irradiation for Children and Young Adults with Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Allogeneic Hematopoietic Cell Transplantation: Prospective Phase II Trial of the Pediatric Blood and Marrow Transplant Consortium. Biol Blood Marrow Transplant. 2018 08;24(8):1651-1656. PMCID: PMC6108922
39. Hochberg J, Zahler S, Geyer MB, Chen N, Krajewski J, Harrison L, Militano O, Ozkaynak MF, Cheerva AC, Talano J, Moore TB, Gillio AP, Walters MC, Baxter-Lowe LA, Hamby C, Cairo MS. The safety and efficacy of clofarabine in combination with high-dose cytarabine and total body irradiation myeloablative conditioning and allogeneic stem cell transplantation in children, adolescents, and young adults (CAYA) with poor-risk acute leukemia. Bone Marrow Transplant. 2019 02;54(2):226-235.
40. Jacobsohn DA, Loken MR, Fei M, Adams A, Brodersen LE, Logan BR, Ahn KW, Shaw BE, Kletzel M, Olszewski M, Khan S, Meshinchi S, Keating A, Harris A, Teira P, Duerst RE, Margossian SP, Martin PL, Petrovic A, Dvorak CC, Nemecek ER, Boyer MW, Chen AR, Davis JH, Shenoy S, Savasan S, Hudspeth MP, Adams RH, Lewis VA, Kheradpour A, Kasow KA, Gillio AP, Haight AE, Bhatia M, Bambach BJ, Haines HL, Quigg TC, Greiner RJ, Talano JM, Delgado DC, Cheerva A, Gowda M, Ahuja S, Ozkaynak M, Mitchell D, Schultz KR, Fry TJ, Loeb DM, Pulsipher MA. Outcomes of Measurable Residual Disease in Pediatric Acute Myeloid Leukemia before and after Hematopoietic Stem Cell Transplant: Validation of Difference from Normal Flow Cytometry with Chimerism Studies and Wilms Tumor 1 Gene Expression. Biol Blood Marrow Transplant. 2018 10;24(10):2040-2046. PMCID: PMC6239928
41. Allen CE, Marsh R, Dawson P, Bollard CM, Shenoy S, Roehrs P, Hanna R, Burroughs L, Kean L, Talano JA, Schultz KR, Pai SY, Baker KS, Andolina JR, Stenger EO, Connelly J, Ramirez A, Bryant C, Eapen M, Pulsipher MA. Reduced-intensity conditioning for hematopoietic cell transplant for HLH and primary immune deficiencies. Blood. 2018 09 27;132(13):1438-1451. PMCID: PMC6161764
42. Bhatt NS, Brazauskas R, Tecca HR, Carreras J, Burns LJ, Phelan R, Salit RB, Syrjala KL, Talano JM, Shaw BE. Post-transplantation employment status of adult survivors of childhood allogeneic hematopoietic cell transplant: A report from the Center for International Blood and Marrow Transplant Research (CIBMTR). Cancer. 2019 01 01;125(1):144-152. PMCID: PMC6310211
43. Broglie L, Phelan R, Talano JA. First report that prior ECMO therapy does not preclude hematopoietic cell transplantation. Pediatr Hematol Oncol. 2018 May;35(4):245-249.
44. Broglie L, Vitola B, Thakar MS, Basel D, Szabo S, Agni R, Talano JA. Hemophagocytic lymphohistiocytosis mimicking neonatal hemochromatosis. Pediatr Hematol Oncol. 2019 Oct;36(7):451-456.
45. Thakar MS, Talano JAM, Tower RL, Kelly ME, Burke MJ. Indications for transplantation in childhood acute leukemia and the impact of minimal residual disease on relapse: A review Clinical Practice. January 2014;11(1):79-90.
46. Bhatt NS, Oshrine B, An Talano J. Hemophagocytic lymphohistiocytosis in adults. Leuk Lymphoma. 2019 01;60(1):19-28.
47. McArthur JA, Bambach B, Duncan C, Talano JA, Tamburro RT. Critical Illness Involving Children Undergoing Hematopoietic Progenitor Cell Transplantation Pediatric Critical Care. 2011:1177-1190.
48. Talano JAM, Casper JT, Margolis DA. Hematopoietic Cell Transplantation for Childhood Acute Myeloid Leukemia Thomas' Hematopoietic Cell Transplantation: Stem Cell Transplantation, Fourth Edition. 5 March 2009:775-790.
49. Cairo MS, Talano JA, Moore TB, Shi Q, Weinberg RS, Grossman B, Shenoy S. Familial Haploidentical Stem Cell Transplant in Children and Adolescents With High-Risk Sickle Cell Disease: A Phase 2 Clinical Trial. JAMA Pediatr. 2020 02 01;174(2):195-197. PMCID: PMC6902105
50. Seif AE, Li Y, Monos DS, Heidemann SC, Aplenc R, Barrett DM, Casper JT, Freedman JL, Grupp SA, Margolis DA, Olson TS, Teachey DT, Keever-Taylor CA, Wang Y, Talano JM, Bunin NJ. Partially CD3<sup>+</sup>-Depleted Unrelated and Haploidentical Donor Peripheral Stem Cell Transplantation Has Favorable Graft-versus-Host Disease and Survival Rates in Pediatric Hematologic Malignancy. Biol Blood Marrow Transplant. 2020 03;26(3):493-501.
51. Levine JE, Antin JH, Allen CE, Burroughs LM, Cooke KR, Devine S, Heslop H, Nakamura R, Talano JA, Yanik G, DiFronzo N. Priorities for Improving Outcomes for Nonmalignant Blood Diseases: A Report from the Blood and Marrow Transplant Clinical Trials Network. Biol Blood Marrow Transplant. 2020 05;26(5):e94-e100. PMCID: PMC8062984
52. Blincoe A, Heeg M, Campbell PK, Hines M, Khojah A, Klein-Gitelman M, Talano JA, Speckmann C, Touzot F, Lankester A, Legger GE, Rivière JG, Garcia-Prat M, Alonso L, Putti MC, Lehmberg K, Maier S, El Chazli Y, Elmaksoud MA, Astigarraga I, Kurjane N, Bulina I, Kenina V, Bryceson Y, Rascon J, Lortie A, Goldstein G, Booth C, Worth A, Wassmer E, Schmitt EG, Warren JT, Bednarski JJ, Ali S, Chiang KY, Krueger J, Henry MM, Holland SM, Marsh RA, Ehl S, Haddad E. Neuroinflammatory Disease as an Isolated Manifestation of Hemophagocytic Lymphohistiocytosis. J Clin Immunol. 2020 08;40(6):901-916.
53. Moskop A, Pommert L, Thakrar P, Talano J, Phelan R. Chimeric antigen receptor T-cell therapy for marrow and extramedullary relapse of infant acute lymphoblastic leukemia. Pediatr Blood Cancer. 2021 01;68(1):e28739.
54. Friedman D, Dozor AJ, Milner J, D'Souza M, Talano JA, Moore TB, Shenoy S, Shi Q, Walters MC, Vichinsky E, Parsons SK, Braniecki S, Moorthy CR, Ayello J, Flower A, Morris E, Mahanti H, Fabricatore S, Klejmont L, van de Ven C, Baxter-Lowe LA, Cairo MS. Stable to improved cardiac and pulmonary function in children with high-risk sickle cell disease following haploidentical stem cell transplantation. Bone Marrow Transplant. 2021 09;56(9):2221-2230. PMCID: PMC8416746
55. Kharfan-Dabaja MA, Kumar A, Ayala E, Aljurf M, Nishihori T, Marsh R, Burroughs LM, Majhail N, Al-Homsi AS, Al-Kadhimi ZS, Bar M, Bertaina A, Boelens JJ, Champlin R, Chaudhury S, DeFilipp Z, Dholaria B, El-Jawahri A, Fanning S, Fraint E, Gergis U, Giralt S, Hamilton BK, Hashmi SK, Horn B, Inamoto Y, Jacobsohn DA, Jain T, Johnston L, Kanate AS, Kansagra A, Kassim A, Kean LS, Kitko CL, Knight-Perry J, Kurtzberg J, Liu H, MacMillan ML, Mahmoudjafari Z, Mielcarek M, Mohty M, Nagler A, Nemecek E, Olson TS, Oran B, Perales MA, Prockop SE, Pulsipher MA, Pusic I, Riches ML, Rodriguez C, Romee R, Rondon G, Saad A, Shah N, Shaw PJ, Shenoy S, Sierra J, Talano J, Verneris MR, Veys P, Wagner JE, Savani BN, Hamadani M, Carpenter PA. Standardizing Definitions of Hematopoietic Recovery, Graft Rejection, Graft Failure, Poor Graft Function, and Donor Chimerism in Allogeneic Hematopoietic Cell Transplantation: A Report on Behalf of the American Society for Transplantation and Cellular Therapy. Transplant Cell Ther. 2021 08;27(8):642-649.
56. Rossoff J, Baggott C, Prabhu S, Pacenta H, Phillips CL, Stefanski H, Talano JA, Moskop A, Margossian SP, Verneris MR, Myers GD, Karras N, Brown PA, Qayed M, Hermiston M, Satwani P, Krupski C, Keating AK, Wilcox R, Rabik CA, Fabrizio VA, Kunicki M, Chinnabhandar V, Goksenin AY, Curran KJ, Mackall CL, Laetsch TW, Schultz LM. Out-of-specification tisagenlecleucel does not compromise safety or efficacy in pediatric acute lymphoblastic leukemia. Blood. 2021 Nov 25;138(21):2138-2142.
 
Books, Chapters, and Reviews
1. Talano JM, Margolis DA. Recent Molecular and Cellular Advances. In: Pediatric Bone Marrow Transplantation. Pediatric Clinics of North America. Vol 53. 2006:685-698.
2. Talano JM, Casper J, Margolis D. Hematopoietic Cell Transplant for Childhood Acute Myeloid Leukemia. In: Appelbaum F, Forman S, Negrin R, Blume K, eds. Thomas' Hematopoietic Cell Transplantation, 4th edition. Massachusetts: Blackwell Publishing, 2009.
3. McArthur J, Bambach B, Duncan C, Talano J, Tamburro B. Critical Illness Involving Children Undergoing Hematopoietic Stem Cell Transplant. In: Fuhrman and Zimmerman, eds. Pediatric Critical Care, 4th edition. New York: Elsevier Publishing, 2011.
4. Erker C, Harker-Murray P, Talano J. Usual and Unusual Manifestations of Familial Hemophagocytic Lymphohistiocytosis and Langerhans Cell Histiocytosis. Accepted for publication. Pediatric Clinics of North America.
5. McArthur J, Bambach B, Duncan C, Talano J, Tamburro B. Critical Illness Involving Children Undergoing Hematopoietic Stem Cell Transplant. In: Fuhrman and Zimmerman, eds. Pediatric Critical Care, 5th edition. New York: Elsevier Publishing, 2017
6. Dobrozi S, Talano J, Camitta B. Hematopoetic Cell Transplants for Children with Acute Lymphoblastic Leukemia. In Hillard Lazarus, Hematopoetic Cell Transplants Concepts, Controversies and Future Directions, Cambridge University Press 2017
7. Duncan C, Talano J, McArthur J. Editors: Critical Care of the Pediatric Immunocompromised Hematology Oncology Patient. An Evidence Based Guide. Springer International Publishing 2019
8. Hines M, Bhatt N, Talano J. Diagnosis, Treatment and Management of Hemophagocytic Lymphohistiocytosis in the Critical Care Unit. Critical Care of the Pediatric Immunocompromised Hematology Oncology Patient. Springer International Publishing 2019
 
Abstracts
1. Talano, J.; Katz, B. Z. "Outcome of Fever of Unknown Origin in Children." Presented at the Infectious Diseases Society of America 36th Annual Meeting, November, 1998.
2. Talano, J.; Johnson, S.; Gottschall, J.L.; Curtis, B.R.; Scott, J.P. "IgA- Mediated Autoimmune Hemolytic Anemia Detected by Flow Cytometry Responsive to Cyclosporin A Therapy." Presented at the Pediatric Academic Societies Meeting, May, 2000.
3. Talano, J.; Gottschall, J.L.; Johnson, S.T.; Pugh, T.M.; Hillery, C.A.; Scott, J.P. "Partial Phenotype Matching (Rh, Kell) Reduces Alloimmunization in Children with Sickle Cell Disease." Presented at the American Society of Pediatric Hematology/Oncology 13th Annual Meeting, September, 2000.
4. Talano, J.; Hillery, C.A.; Gottschall, J.L.; Baylerian, D.M.; Scott, J.P. "Delayed Hemolytic Transfusion Reactions in Sickle Cell Disease." Presented at the American Society of Pediatric Hematology/ Oncology 14th Annual Meeting, April, 2001.Presented at the Annual Sickle Cell Meeting, April 2001.
5. Talano, J.M.; Johnson, S.T.; Friedman, K.D.; Ilstrup, S.J.; Treisman, J.S.; Curtis, B.R.; Scott, J. P.; Gottschall, J.L. " Serologic Characteristics of Three Cases of IgA Mediated Autoimmune Hemolytic Anemia (AIHA) Confirmed by Flow Cytometry." Presented at the American Society of Hematology Annual Meeting, December 2002.
6. Talano, J.M.; Margolis, D.A.; Camitta, B.M.; Keever-Taylor, C.A.; Murray, K.J.; Eapen, M.; Pierce, K.L.; Casper, J.T. "Outcome of Unrelated and Haploidentical Bone Marrow Transplants in Children with Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL)." Presented at the American Society of Hematology Annual Meeting, December 2002.
7. Talano, J.M.; Keever-Taylor, C.A., Eapen, M., Casper, J.T., Margolis, D.A. "Haploidentical Family Donor Transplants in Children Using High Doses of Positively Selected CD34+ Cells with Low CD3+ Cells: An Initial Report of the Milwaukee Experience." Presented at the American Society of Hematology Annual Meeting, December 2003.
8. Talano, J.M.; Camitta, B.; Keever-Taylor, C.A.; Anderson, L.A.; Wallach, C.; Casper; J. "Long Term Outcomes of Unrelated Donor Bone Marrow Transplantation in Children with Severe Aplastic Anemia: An Update of the Milwaukee Experience. Presented at the National Marrow Donor Program Meeting, November 2006 awarded Best Abstract. Presented at the American Society of Hematology Annual Meeting, December 2006.
9. Prasad V.K., Lucas K.G., Kleiner G.I., Talano J.M., Jacobson D., Szabolcs P., Monroy R., Kurtzberg J. "Use of Mesenchymal Stem Cells to Treat Pediatric Patients with Severe (Grade III-IV) acute Graft versus Host Disease Refractory to Steroid and Other Agents on a Compassionate Use Basis." Presented at the American Society of Hematology Annual Meeting, December 2007
10. McArthur J, Mikalov T, Talano J. Relationship between Acetaminophen Dosage and Development of Organ Dysfunction during Pediatric Hematopoetic Stem Cell Transplant. Presented at the American Society for Blood and Marrow Transplant, February 2009
11. Talano, J, Biank, V, Casper, J, Margolis,D, Stephens. M. Secondary Hemophagocytic Lymphohistiocytosis in Adolescent Patients with Crohn's Disease.Presented at the International Histocyte Society meeting, Bilbao Spain September 2009
12. Talano, J, Brown, J Eastwood, D, McArthur, J, Casper,J, Margolis, D. Analysis of the Incidence and Characteristics of Venoocclusive Disease (VOD) of the Liver in Pediatric Hematopoietic Progenitor Cell Transplant (HPCT) Patients with Heparin alone vs. Heparin and Ursodiol Prophylaxis at the Medical College of Wisconsin. American Society of Bone Marrow Transplant Meeting 2010. American Society of Pediatric Hematology Oncology 2010
13. Szabolics, P, Visani, G, Locatelli,F, Kleiner, G, Talano, J, Nemecek, E, Kurtzberg, J. Treatment of steroid-refractory acute GVHD with mesenchymal stem cells improves outcomes in pediatric patients; Results of the pediatric subset in a phase III randomized, placebo-controlled study. Presented at the American Society of Bone Marrow Transplant Meeting 2010
14. Mulberry, M, Casper, J, Margolis, D, Talano, J. A Case Report of a Pediatric Patient with T Cell Acute Lymphoblastic Leukemia (ALL) CR2 with Neurologic Deficits Secondary to Enterovirus Encephalitis with Substantial Recovery of Function Post Umbilical Cord Transplantation. Presented at the 8th Annual International Umbilical Cord Blood Transplantation Symposium 2010.
15. Rangarajan, H, Grochowski, D, Mulberry, M. Talano, J. Successful Treatment of Recurrent CNS Disease in Familial HLH post Bone Marrow Transplant: Frequent Monitoring and Preemptive Therapy has Shown to be An Effective Treatment Strategy. Presented at the International Histiocyte Meeting. Boston, MA. 2010
16. Angela Ricci, Mark Geyer, Lauren Harrison, Dierdre Duffy, Monica Bhatia, James Garvin, Diane George, Prakash Satwani, Alexa Cheerva, Julie Talano, M. Fevzi Ozkaynak, Theodore Moore, Joseph Schwartz, LeeAnn Baxter-Lowe, Mitchell S. Cairo. Pediatrics, Columbia University, New York, NY; Pediatrics, University of Louisville, Louisville, KY; Pediatrics, Medical College of Wisconsin, Milwaukee, WI; Pediatrics, New York Medical College, Valhalla, NY; Pediatrics, Univeristy of California Los Angeles, Los Angeles, CA; Pathology and Cell Biology, Columbia University, New York, NY; Surgery, University of California San Francisco, San Francisco, CA; Medicine, Columbia University, New York, NY. Preliminary Results of Phase I/II Study of Clofarabine (CLO) in Combination with Cytarabine (ARA-C) and Total Body Irradiation (TBI) Followed by Allogeneic Stem Cell Transplantation (AlloSCT) in Children, Adolescents and Young Adults (CAYA) with Poor-Risk Acute Leukemia Presented at American Society of Hematology Oral Presentation 2010, Pediatric Academic Society Meeting, Denver, CO 2011, ASBMT 2011
17. Radhakrishnan,K.Talano,J.Taylor,C.Bhatia,M.Shenoy,S.Walters,M.Parsons,S.Morris,E.Baxter-Lowe,L.A.Cairo,M. Familial Haploidentical (FHI) T-cell Depleted(TCD)Transplantation in High-Risk Sickle Cell Disease (SCD). American Society of Blood and Marrow Transplant Annual Meeting 2011
18. Rangarajan,H. Cogbill,C. Grochowski,D. Georghe, G. Talano, J. Systemic EBV-Positive T cell Lymphoproliferative Disease of Childhood: A Case Report. American Society Pediatric Hematology Oncology 2012
19. Talano, J., Keever Taylor, C., Shenoy, S., Walters, M., Radhakrishnan, K., Parsons, S., Morris, E., Baxter-Lowe, L.A., Moore, T., Cairo, M. Familial haploidentical (FHI) T-cell depleted (TCD) with Tcell addback stem cell transplantation in children with high-risk sickle cell disease (SCD) (IND14359) (RO1FD004090-01A1). Presented, American Society of Pediatric Hematology/Oncology 26th Annual Meeting. Pediatric Blood & Cancer 60 (S2) 2013;S99 #915.
20. Burroughs, L., Nemecek, E., Torgerson, T., Gutherie, K., Talano, J., Domm, J., Shimamura, A., Carpenter, P., Skoda-Smith, S.,Englund, J., Baker, KS., Storb, R., Woolfrey, A. Treosulfan Based Conditioning Followed by Allogeneic Hematopoietic Cell Transplantation for Treatment of Patients with Non-Malignant Diseases: Preliminary Results of a Phase II Study. Presented, American Society of Blood and Marrow Transplant Annual Meeting, Biology of Blood and Marrow Transplantation Vol. 19, Issue 2, Supplement, Page S158. 2013
21. Chen, N., Radhakrishnan, K., Krajewski, J., Ricci, A.M., Geyer, M., Harrison, L., Ozkaynak, M.F., Cheerva, A.C., Talano, J., Moore, T., Gillio, A., Baxter-Lowe, L-A., Cairo, M. Low day 100 transplant related mortality and relapse rate following clofarabine in combination with cytarabine, total body irradiation and allogeneic stem cell transplantation in children, adolescents and young adults with poor-risk acute leukaemia. Presented, American Society of Pediatric Hematology/Oncology 26th Annual Meeting. Pediatric Blood & Cancer 60 (S2) 2013;S95 #902. Presented, European Group for Blood and Marrow Transplantation. Bone Marrow Transplantation 2013; 48(2):S280 #P870. Presented, Eastern Society for Pediatric Research, 2013. 2013 ESPR Annual Meeting: 59 #154. Presented, 2013 BMT Tandem Meetings. Biology of Blood and Marrow Transplantation 2013; 19(2) Supp 2:S251 #278.
22. Bajwa, R., McArthur, J., Talano, J., Fitzgerald, J., Duncan, C., Margossian, S., Yates, A., Hall, M., Cunnigham, S., Spear, D., Luther, K., Tamburro, R. Assessment of Brain Natriuretic Peptide in Patients Undergoing Hematopoietic Stem Cell Transplantation. Presented at 2013 American Society of Blood and Marrow Transplant Meeting. Biology of Blood and Marrow Transplantation Vol. 19, Issue 2, Supplement, Pages S257-S258
23. . Rangarajan, H., Punzalan, R., Talano, J., The Safety and Tolerability of the Novel Therakos Cellex Machine for Extracorporeal Photopheresis in the Treatment of GVHD in Children. . Presented at 2013 American Society of Blood and Marrow Transplant Meeting. Biology of Blood and Marrow Transplantation Vol. 19, Issue 2, Supplement, Page S255
24. Kurtzberg, J., Prockop, S., Teira, P., Bittencourt, H., Lewis, V., Chan, K., Horn, B., Yu, L., Talano, J. et al. Allogeneic Human Mesenchymal Stem Cell Therapy (Remestemcel-L, Prochymal) as a Rescue Agent for Severe Refractory Acute Graft-versus-Host Disease in Pediatric Patients Biology of Blood and Marrow Transplant, Vol. 20, Issue 2, p229–235
25. Talano, J., Keever-Taylor, C., Walters, M., Shenoy, S., Moore, T., Parsons, S., Abikoff, C., Dozor, A., Friedman, D., Chitti, R., Shi, Q., Grossman, B., Weinberg, R., Morris, E., Brand, P., Mangan, D., Foley, S., Militano, O., Ayello, J., Semidei-Pomales, M., Baxter-Lowe, L., Cairo, M. Familial Haploidentical (FHI) T-Cell Depleted (TCD) with T-Cell Addback Stem Cell Transplantation for Patients with High-Risk Sickle Cell Disease (SCD) (IND 14359) Presented at 2014 American Society of Blood and Marrow Transplant Meeting. Biology of Blood and Marrow Transplantation Vol. 20, Issue 2, Supplement, Pages S135-S13
26. Satwani, P., Jin,Z., Bhatia, M., Garvin, J., George, D., Chaudhury, S., Talano, J., Sosna, J., Morris, E., Harrison, L., Martin, P., Peterson, M., Kurtzberg, J., Cairo, M. Sequential Myeloablative Autologous Stem Cell Transplantation and Reduced Intensity Allogeneic Stem Cell Transplantation in Children, Adolescents and Young Adults with Poor Risk Refractory or Recurrent Hodgkin (HL) and Non-Hodgkin Lymphoma (NHL) Oral Presentation at 2014 American Society of Blood and Marrow Transplant Meeting. Biology of Blood and Marrow Transplantation. Biology of Blood and Marrow Transplantation Vol. 20, Issue 2, Supplement, Page S85
27. . Chen, N., Radhakrishnan, K., Krajewski, J., Ricci, A., Geyer, M., Harrison, L., Ozkaynak, M., Cheerva, A., Talano, J., Moore, T., Gillio, A., Walters, M., Baxter-Lowe, L., Cairo, M. Low Day 100 Transplant-Related Mortality and Relapse Rate Following Clofarabine in Combination with Cytarabine, Total Body Irradiation and Allogenic Stem Cell Transplantaiton in Children, Adolescents and Young Adults with Poor-Risk Acute Leukemia. Oral Presentation at 2014 American Society of Blood and Marrow Transplant Meeting. Biology of Blood and Marrow Transplantation Vol. 20, Issue 2, Supplement, Pages S79-S80
28. Talano, J. M., J. Brown, J. T. Casper, M. Mulberry, D. Eastwood, K. W. Ahn and D. A. Margolis "Analysis Of The Incidence And Characteristics Of Venoocclusive Disease (VOD) Of The Liver In Pediatric Hematopoietic Progenitor Cell Transplant (HPCT) Patients With Heparin Alone Vs. Heparin And Ursodiol Prophylaxis At The Medical College Of Wisconsin." Biology of Blood and Marrow Transplantation 16(2): S248.
29. Talano, J., et al. Familial Haploidentical (FHI) Allogeneic Stem Cell Transplantation Utilizing CD34 Enrichment and T Cell Addback in Children, Adolescents & Adults with High-Risk Sickle Cell Disease. Rapid Engraftment, Immune Reconstitution, Low Incidence of GVHD, and Sustained Donor Chimerism. J Talano ASPHO Annual Meeting Oral presentation May 2016 Minneapolis Pediatric Blood and Cancer Volume 63, Issue S1, June 2016
30. Nemecek, E., Adams, A., Shaw, B., Kiefer, Deidre M., Le-Rademacher, J., Levine, J.,Yanik, G.,.Leung, W.,Talano, J., et al. Phase II Study of Treosulfan/Fludarabine/ Low Dose Total Body Irradiation As a Preparative Regimen for Children with Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS) Undergoing Allogeneic Hematopoietic Cell Transplantation. Oral Presentation ASBMT Honolulu HI 2016 Biology of Blood and Marrow Transplant, Vol. 22, Issue 3, S99
31. Chu, Y., Brand, P., Morris, E., Lee, F., Talano, J., Shenoy, S., Moore, T., Keever-Taylor, C., Weinberg, R., Grossman, B., Cairo, M. Natural Killer Cell Reconstitution Following Familial Haploidentical (FHI) CD34 Enriched Stem Cell Transplantation with T-Cell Add Back in Patients with High Risk Sickle Cell Disease (SCD) (IND 14359) Poster ASBMT Honululu HI 2016. Biology of Blood and Marrow Transplant, Vol. 22, Issue 3, S151–S152
32. Keever-Taylor, C., Weinberg, R., Grossman, B., Shenoy, S., Talano, J., Moore,T., et el. Collection and Processing Outcomes of G-CSF Mobilized Peripheral Blood Stem Cells (PBSC) Collected from Parental Haploidentical Stem Cell Sickle Cell Trait Donors of Patients Undergoing CD34 Enriched Transplantation for High-Risk Sickle Cell Disease Poster ASBMT Honululu HI 2016 Biology of Blood and Marrow Transplant, Vol. 22, Issue 3, S383–S384
33. Seif, A., Li, Y., Aplenc, R., Barrett, R., Casper, J., Freedman, J., Grupp, S., Margolis, D., et al. CD3/CD19 Depletion with Targeted T Cell Add-Back Results in Stable Engraftment and Minimal GVHD in Pediatric Patients with Bone Marrow Failure Undergoing Unrelated Donor Peripheral Blood Stem Cell Transplantation Oral presentation ASBMT Honululu HI 2016 Biology of Blood and Marrow Transplant, Vol. 22, Issue 3, S62–S63
34. Duncan, C., Brazauskas, R., Huang, J., Shaw, B., Majhail, N., Savani, B., Flowers, M., Battiwalla, M., Talano, J. et al. Late Cardiovascular Morbidity Following Pediatric Allogeneic Hematopoietic Cell Transplantation Oral Presentation ASBMT Honululu HI 2016 Biology of Blood and Marrow Transplant, Vol. 22, Issue 3, S60
35. Familial Haploidentical (FHI) Allogeneic Stem Cell Transplantation (AlloSCT) Utilizing CD34 Enrichment and PB MNC Addback in Children and Adolescents with High Risk Sickle Cell Disease (SCD): Rapid Engraftment, Immune Cell Reconstitution, and Sustained Donor Chimerism (IND 14359) Poster American Society of Hematology Annual meeting San Diego, CA 2016
36. Parsons SK, Rodday AM, Weidner RA, Morris E, Moore TB, Shenoy S, Talano J-A, Minzer S, Fabricatore S, Braniecki S, Cairo MS. Trajectories of Children’s Health-Related Quality of Life after Myeloimmuno Ablative Conditioning Familial Haploidentical T-Cell Depleted with T-Cell Addback Stem Cell Transplantation for Poor Risk SCD. Poster Presentation. American Society of Blood and Marrow Transplant Annual Meeting Orlando, FL 2017 Biology of Blood and Marrow Transplantation , Volume 23 , Issue 3 , S227 - S228
37. Newsom S, Bock A, LeVeque M, Talano J, High Dose Corticosteroid Therapy for Treatment of Late Pulmonary Disease Post-HSCT in Children and Adolescents. American Society of Pediatric Hematology/Pediatric Blood and Marrow Transplant Meeting, Montreal Canada 2017 Poster Presentation Pediatric Blood and Cancer, Volume 64, S 98
38. Broglie L, Talano J, Moore T, Shenoy S, Mahanti S, Morris E, Horowitz T, Fabricatore S, Abikoff C, Dozor A, Cairo M. Stabilization of Pulmonary Function in Pediatric and Young Adult Sickle Cell Disease (SCD) Recipients Undergoing Myelo-immunesuppressive (MIC) and Familial Haploidentical (FHI) Transplantation Enriched CD34 Selection and T-cell add back. American Society of Pediatric Hematology/Pediatric Blood and Marrow Transplant Meeting, Montreal Canada 2017 Poster Presentation Pediatric Blood and Cancer, Volume 64, S99
39. Braniecki S, Talano J, Moore T, Weinberg R,. Keever-Taylor C, Grossman B, Baxter-Lowe L, Parsons S, Morris E, Fabricatore S, Neurocogntive and Neurological Outcomes in Children Adolescents and Young Adults with High Risk Sickle Cell Disease (SCD) who have Undergone Familial Haploidentical (FHI) Allogeneic Stem Cell Transplantation Utilizing CD34 Enrichment and T Cell Addback Following Myeloimmunoablative Conditioning (MIC) American Society of Pediatric Hematology/Pediatric Blood and Marrow Transplant Meeting, Montreal Canada 2017 Poster Presentation Pediatric Blood and Cancer, Volume 64, S100
40. Broglie L, Pommert L, Rao S, Thakar M, Phelan R, Margolis D ,Talano J. Ruxolitinib for treatment of refractory hemophagocytic lymphohistiocytosis. Histiocyte Annual Meeting Singapore 2017
41. Yara Perez, Liana Klejmont, Harshini Mahanti, Jessica Hochberg, Allyson Flower, Qiuhu Shi, Theodore B. Moore, Julie-An M. Talano et al. Elevated Pre-HSCT Ferritin is Not Associated with Increased Risk of Acute Graft Versus Host Disease in Patients with High Risk Sickle Cell Disease Undergoing Haploidentical T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation (AlloHSCT) ASBMT February 2018
42. Allyson Flower, Julie-An M. Talano, Theodore B. Moore, Shalini Shenoy, Larisa Broglie, Harshini Mahanti, Erin Morris, Sandra Fabricatore et al. Stable Pulmonary Function after Myeloimmunosupressive Conditioning (MIC) and Familial Haploidentical (FHI) Transplantation Utilizing CD34+ Enrichment and PBMC (CD3) Add Back in Children and Young Adults with High Risk (HR) Sickle Cell Disease (SCD) ASBMT February 2018
43. Cairo, M., Parsons, S. K., Braniecki, S., Talano, J., Moore, T. B., Shi, Q., Keever-Taylor, C. A., Weinberg, R. S., Grossman, B. J., Dozor, A. J., Friedman, D., McKinstry, R. C., Verbsky, J., Moorthy, C. R., Weidner, R. A., Rodday, A. M., Ayello, J., Semidei-Pomales, M., Flower, A. M., Chu, Y., Morris, E., Mahanti, H., Fabricatore, S., Militano, O., Klejmont, L., van de Ven, C., Baxter-Lowe, L. A., Vichinsky, E., Walters, M. C., & Shenoy, S. (2018). Significantly Improved Long Term Health Related Quality of Life (HRQL) and Neurocognition Following Familial Haploidentical Stem Cell Transplantation (HISCT) Utilizing CD34 Enrichment and Mononuclear (CD3) Addback in High Risk Patients with Sickle Cell Disease (SCD). Blood, 132(Suppl 1), 162. Oral Presentation ASH 2018 https://doi.org/10.1182/blood-2018-162.
44. Yaya Chu, Julie-An Talano, Lee Ann Baxter-Lowe, Carolyn A. Keever-Taylor, Erin Morris, Harshini Mahanti, Janet Ayello, Rona Singer Weinberg, Qiuhu Shi, Theodore B. Moore, Sandra Fabricatore, Brenda J. Grossman, Carmella van de Ven, Shalini Shenoy, Mitchell S Cairo; Sustained Donor Chimerism and Rapid Immune Cell Reconstitution Following Familial Haploidentical (FHI) CD34 Enriched Stem Cell Transplantation with Pbmnc Addback in Patients with High Risk Sickle Cell Disease (SCD) (IND 14359). Blood 2019; 134 (Supplement_1): 1990. doi: https://doi.org/10.1182/blood-2019-126757
45. Hisham Abdel-Azim, Christopher C. Dvorak, Nancy Bunin, Mark C. Walters, Julie-An Talano, Eric Jon Anderson, Jemily Malvar, May Al Jassani, Sonali Chaudhury, Mitchell S Cairo, Carrie Kitko, Allison P. Jacob, Dimitri S. Monos, Leung Wing, Michael A. Pulsipher; Next Generation Sequence Minimal Residual Disease (NGS-MRD) Predicts Outstanding Event Free Survival (EFS) Regardless of Hematopoietic Cell Transplantation (HCT) Preparative Approach or Graft Alpha/Beta Depletion in Children with Acute Lymphoblastic Leukemia (ALL). Blood 2019; 134 (Supplement_1): 4624. doi: https://doi.org/10.1182/blood-2019-131706
46. Allyson Flower, Janet Ayello, Lauren Harrison, Erin Morris, Meghan Sturhahn, Elena Maryamchik, Yongping Wang, Lynn O’Donnell, Rolla Abu-Arja, Dean Lee, Julie-An M. Talano, Bryon D Johnson, Mitchell S. Cairo. The Safety and Efficacy of Targeted Virus Specific Cytotoxic T-Lymphocytes (VST) Manufactured By the IFN-g Cytokine Capture System (CCS) for the Treatment of Refractory Adenovirus (ADV), Cytomegalovirus (CMV), Epstein Barr Virus (EBV) and BK Virus (BKV) in Children, Adolescents and Young Adults (CAYA) after Allogenic Hematopoietic Stem Cell Transplantation (Allo-HSCT), Solid Organ Transplantation (SOT), or with Primary Immunodeficiency (PID) (IND# 17449). Oral Presentation TCT Orlando FL 2020
47. Boyer M, Chaudhury S, Davis K, Driscoll T, Grupp S, Hermiston M, John S, Keating A, Kovacs C, Myers GD, Phillips C, Pulsipher M, Talano JA, Kari G, Willert J. Evaluating Efficacy and Safety of Tisagenlecleucel Reinfusion Following Loss of B-Cell Aplasia in Pediatric and Young Adult Patients With Acute Lymphoblastic Leukemia: HESTER Phase II Study. Poster Session. Society of Hematologic Oncology (SOHO) Annual Meeting. 09/2021